- 現金殖利率: 3.33%、總殖利率: 3.33%、5年平均現金配發率: 77.45%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 1.05 | -71.07 | 1.00 | -62.83 | 0.00 | 0 | 95.24 | 28.52 | 0.00 | 0 | 95.24 | 28.52 |
2022 (9) | 3.63 | -4.97 | 2.69 | -10.03 | 0.00 | 0 | 74.10 | -5.32 | 0.00 | 0 | 74.10 | -5.32 |
2021 (8) | 3.82 | 72.85 | 2.99 | 88.05 | 0.00 | 0 | 78.27 | 8.79 | 0.00 | 0 | 78.27 | 8.79 |
2020 (7) | 2.21 | -16.92 | 1.59 | -11.67 | 0.00 | 0 | 71.95 | 6.32 | 0.00 | 0 | 71.95 | 6.32 |
2019 (6) | 2.66 | 23.72 | 1.80 | 20.0 | 0.00 | 0 | 67.67 | -3.01 | 0.00 | 0 | 67.67 | -3.01 |
2018 (5) | 2.15 | 31.1 | 1.50 | 11.11 | 0.00 | 0 | 69.77 | -15.25 | 0.00 | 0 | 69.77 | -21.09 |
2017 (4) | 1.64 | -21.15 | 1.35 | 3.85 | 0.10 | -50.0 | 82.32 | 31.71 | 6.10 | -36.59 | 88.41 | 22.6 |
2016 (3) | 2.08 | 0.48 | 1.30 | 0.0 | 0.20 | 0.0 | 62.50 | -0.48 | 9.62 | -0.48 | 72.12 | -0.48 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 0.08 | -82.61 | -82.98 | 0.13 | -55.17 | 85.71 | 1.03 | 8.42 | -20.16 |
24Q2 (19) | 0.46 | -8.0 | 17.95 | 0.29 | 93.33 | 262.5 | 0.95 | 90.0 | 15.85 |
24Q1 (18) | 0.50 | 308.33 | 16.28 | 0.15 | 15.38 | -68.75 | 0.50 | -52.38 | 16.28 |
23Q4 (17) | -0.24 | -151.06 | -380.0 | 0.13 | 85.71 | -55.17 | 1.05 | -18.6 | -71.31 |
23Q3 (16) | 0.47 | 20.51 | -66.43 | 0.07 | -12.5 | -87.93 | 1.29 | 57.32 | -65.23 |
23Q2 (15) | 0.39 | -9.3 | -68.55 | 0.08 | -83.33 | -91.21 | 0.82 | 90.7 | -64.35 |
23Q1 (14) | 0.43 | 960.0 | -59.43 | 0.48 | 65.52 | -32.39 | 0.43 | -88.25 | -59.43 |
22Q4 (13) | -0.05 | -103.57 | -111.11 | 0.29 | -50.0 | -30.95 | 3.66 | -1.35 | -4.94 |
22Q3 (12) | 1.40 | 12.9 | 258.97 | 0.58 | -36.26 | 41.46 | 3.71 | 61.3 | 9.12 |
22Q2 (11) | 1.24 | 16.98 | -47.01 | 0.91 | 28.17 | 282.0 | 2.30 | 116.98 | -23.59 |
22Q1 (10) | 1.06 | 135.56 | 58.21 | 0.71 | 69.05 | -14.46 | 1.06 | -72.47 | 58.21 |
21Q4 (9) | 0.45 | 15.38 | 462.5 | 0.42 | 2.44 | 44.83 | 3.85 | 13.24 | 73.42 |
21Q3 (8) | 0.39 | -83.33 | 0.0 | 0.41 | 182.0 | -21.15 | 3.40 | 12.96 | 58.14 |
21Q2 (7) | 2.34 | 249.25 | 229.58 | -0.50 | -160.24 | -158.82 | 3.01 | 349.25 | 71.02 |
21Q1 (6) | 0.67 | 737.5 | -36.19 | 0.83 | 186.21 | -17.0 | 0.67 | -69.82 | -36.19 |
20Q4 (5) | 0.08 | -79.49 | -66.67 | 0.29 | -44.23 | -38.3 | 2.22 | 3.26 | -16.85 |
20Q3 (4) | 0.39 | -45.07 | 0.0 | 0.52 | -38.82 | 0.0 | 2.15 | 22.16 | 0.0 |
20Q2 (3) | 0.71 | -32.38 | 0.0 | 0.85 | -15.0 | 0.0 | 1.76 | 67.62 | 0.0 |
20Q1 (2) | 1.05 | 337.5 | 0.0 | 1.00 | 112.77 | 0.0 | 1.05 | -60.67 | 0.0 |
19Q4 (1) | 0.24 | 0.0 | 0.0 | 0.47 | 0.0 | 0.0 | 2.67 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 0.77 | -18.88 | -26.64 | 13.41 | -4.27 | 3.46 | N/A | - | ||
2024/9 | 0.95 | -45.37 | -34.86 | 12.64 | -2.46 | 3.72 | 2.27 | - | ||
2024/8 | 1.74 | 68.13 | -0.16 | 11.7 | 1.63 | 4.14 | 2.04 | - | ||
2024/7 | 1.03 | -24.74 | 3.23 | 9.96 | 1.95 | 4.22 | 2.0 | - | ||
2024/6 | 1.37 | -24.39 | -10.43 | 8.93 | 1.8 | 4.6 | 1.88 | - | ||
2024/5 | 1.82 | 28.93 | 17.81 | 7.55 | 4.4 | 5.15 | 1.68 | - | ||
2024/4 | 1.41 | -26.89 | 41.45 | 5.74 | 0.77 | 4.48 | 1.93 | - | ||
2024/3 | 1.93 | 68.6 | -0.91 | 4.33 | -7.85 | 4.33 | 2.18 | - | ||
2024/2 | 1.14 | -9.23 | -29.74 | 2.4 | -12.75 | 2.87 | 3.29 | - | ||
2024/1 | 1.26 | 170.59 | 11.78 | 1.26 | 11.78 | 2.52 | 3.75 | - | ||
2023/12 | 0.47 | -41.33 | -8.54 | 15.27 | -38.69 | 2.31 | 4.26 | - | ||
2023/11 | 0.79 | -24.41 | -12.27 | 14.81 | -39.32 | 3.3 | 2.98 | - | ||
2023/10 | 1.05 | -27.97 | -16.3 | 14.01 | -40.36 | 4.25 | 2.31 | - | ||
2023/9 | 1.46 | -16.27 | -12.98 | 12.96 | -41.72 | 4.2 | 2.21 | - | ||
2023/8 | 1.74 | 73.86 | -41.5 | 11.51 | -44.06 | 4.27 | 2.17 | - | ||
2023/7 | 1.0 | -34.71 | -70.0 | 9.77 | -44.49 | 4.07 | 2.28 | 受到中國經濟委靡因素影響,致市場縮小 | ||
2023/6 | 1.53 | -0.55 | -39.15 | 8.77 | -38.52 | 4.07 | 2.04 | - | ||
2023/5 | 1.54 | 54.79 | -49.19 | 7.23 | -38.39 | 4.48 | 1.85 | - | ||
2023/4 | 1.0 | -48.78 | -58.16 | 5.69 | -34.62 | 4.57 | 1.82 | 係因南美洲需求下降及原料價格下跌,客戶端尚在去化庫存,以致出口衰退 | ||
2023/3 | 1.94 | 19.54 | -28.78 | 4.7 | -25.77 | 4.7 | 1.86 | - | ||
2023/2 | 1.63 | 44.4 | 13.3 | 2.75 | -23.48 | 3.26 | 2.67 | - | ||
2023/1 | 1.13 | 121.37 | -47.91 | 1.13 | -47.91 | 2.54 | 3.43 | - | ||
2022/12 | 0.51 | -43.72 | -62.94 | 24.91 | 19.25 | 2.67 | 3.49 | 係植物保護劑與地工合成材料皆有提早於上半年度出貨之情形,以致12月營收較去年同期減少。 | ||
2022/11 | 0.9 | -27.89 | -43.59 | 24.4 | 25.03 | 3.83 | 2.43 | - | ||
2022/10 | 1.25 | -25.11 | -41.46 | 23.5 | 31.17 | 5.9 | 1.58 | - | ||
2022/9 | 1.67 | -43.71 | -15.41 | 22.25 | 41.03 | 7.98 | 1.05 | - | ||
2022/8 | 2.97 | -10.84 | 96.43 | 20.57 | 49.13 | 8.83 | 0.95 | 係因南美洲大宗經濟作物價格上漲致使農藥需求增加,以致今年出口巴西增加。 | ||
2022/7 | 3.34 | 32.43 | 138.38 | 17.6 | 43.3 | 8.89 | 0.95 | 係因南美洲大宗經濟作物價格上漲致使農藥需求增加,以致今年出口巴西增加。 | ||
2022/6 | 2.52 | -16.96 | 74.32 | 14.26 | 31.07 | 7.93 | 1.06 | 係因南美洲大宗經濟作物價格上漲致使農藥需求增加,以致今年出口巴西增加。 | ||
2022/5 | 3.03 | 27.46 | 33.38 | 11.74 | 24.45 | 8.14 | 1.04 | - | ||
2022/4 | 2.38 | -12.81 | 24.94 | 8.71 | 21.61 | 6.55 | 1.29 | - | ||
2022/3 | 2.73 | 90.18 | 18.23 | 6.33 | 20.4 | 6.33 | 1.48 | - | ||
2022/2 | 1.44 | -33.61 | 12.59 | 3.6 | 22.1 | 4.97 | 1.89 | - | ||
2022/1 | 2.16 | 57.51 | 29.36 | 2.16 | 29.36 | 5.14 | 1.83 | - | ||
2021/12 | 1.37 | -14.35 | 24.96 | 20.89 | 13.53 | 5.12 | 1.78 | - | ||
2021/11 | 1.6 | -25.15 | 47.76 | 19.52 | 12.8 | 5.72 | 1.59 | - | ||
2021/10 | 2.14 | 8.2 | 136.81 | 17.91 | 10.46 | 5.64 | 1.62 | 因去年受疫情影響以致巴西客戶訂單減少,而今年疫情趨緩本月出口巴西增加所致。 | ||
2021/9 | 1.98 | 30.71 | 69.03 | 15.77 | 3.0 | 4.89 | 1.71 | 因去年受疫情影響以致巴西客戶訂單減少,而今年疫情趨緩本月出口巴西增加所致。 | ||
2021/8 | 1.51 | 8.19 | 31.85 | 13.79 | -2.46 | 4.36 | 1.92 | - | ||
2021/7 | 1.4 | -3.15 | -10.39 | 12.28 | -5.49 | 5.12 | 1.63 | - | ||
2021/6 | 1.45 | -36.46 | 5.06 | 10.88 | -4.82 | 5.62 | 1.43 | - | ||
2021/5 | 2.27 | 19.4 | 25.44 | 9.43 | -6.17 | 6.49 | 1.24 | - | ||
2021/4 | 1.9 | -17.49 | -14.84 | 7.16 | -13.13 | 5.49 | 1.46 | - | ||
2021/3 | 2.31 | 81.1 | 2.01 | 5.26 | -12.49 | 5.26 | 1.59 | - | ||
2021/2 | 1.27 | -23.72 | -40.38 | 2.95 | -21.27 | 4.04 | 2.07 | - | ||
2021/1 | 1.67 | 52.15 | 4.18 | 1.67 | 4.18 | 3.85 | 2.17 | - | ||
2020/12 | 1.1 | 1.26 | -4.27 | 18.4 | -11.42 | 3.09 | 2.71 | - | ||
2020/11 | 1.08 | 19.94 | 20.82 | 17.3 | -11.83 | 3.16 | 2.65 | - | ||
2020/10 | 0.9 | -22.76 | -34.5 | 16.22 | -13.4 | 3.22 | 2.59 | - | ||
2020/9 | 1.17 | 1.96 | -30.14 | 15.31 | -11.72 | 3.88 | 1.93 | - | ||
2020/8 | 1.15 | -26.47 | -35.66 | 14.14 | -9.75 | 4.09 | 1.83 | - | ||
2020/7 | 1.56 | 13.54 | -9.31 | 12.99 | -6.42 | 4.75 | 1.58 | - | ||
2020/6 | 1.38 | -24.13 | -22.63 | 11.43 | -6.01 | 5.43 | 1.27 | - | ||
2020/5 | 1.81 | -18.95 | -19.7 | 10.06 | -3.17 | 6.31 | 1.09 | - | ||
2020/4 | 2.24 | -1.15 | 2.61 | 8.24 | 1.42 | 6.64 | 1.03 | - | ||
2020/3 | 2.26 | 5.83 | -5.45 | 6.01 | 0.98 | 6.01 | 1.26 | - | ||
2020/2 | 2.14 | 33.29 | 29.66 | 3.74 | 5.32 | 4.89 | 1.55 | - | ||
2020/1 | 1.6 | 39.8 | -15.75 | 1.6 | -15.75 | 3.65 | 2.07 | - | ||
2019/12 | 1.15 | 27.81 | -29.77 | 20.77 | -4.22 | 0.0 | N/A | - | ||
2019/11 | 0.9 | -34.98 | -36.95 | 19.63 | -2.14 | 0.0 | N/A | - |